Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity

Journal: Nature Communications

Published: 2018-02-28

DOI: 10.1038/s41467-018-03335-4

Affiliations: 6

Authors: 15

Go to article
Institutions FC
NIH NIAID Vaccine Research Center (VRC), United States of America (USA) 0.40
Institute for Bioscience and Biotechnology Research (IBBR), United States of America (USA) 0.29
Department of Integrative Structural and Computational Biology (ISCB), Scripps Research, United States of America (USA) 0.13
IAVI's Neutralizing Antibody Center, United States of America (USA) 0.07
Department of Cell Biology and Molecular Genetics (CBMG), UMCP, United States of America (USA) 0.06
Department of Microbiology and Immunology, UMB, United States of America (USA) 0.06

Return